 | Up a level |
Teuwen, Laure-Anne; Ahmad, Zain; Segelov, Eva (2024). Time to Update-Requesting Inclusive Submission Categories for Oncology Research. JCO global oncology, 10, e2400136. American Society of Clinical Oncology 10.1200/GO.24.00136
Wang, Holly; Grech, Lisa; Wong, Jennifer; Hoffman, David; de Courten, Barbora; Sillars, Brett; Savage, Mark; Kwok, Alastair; Nguyen, Mike; Bain, Nathan; Day, Daphne; Segelov, Eva (2024). COVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia. Vaccines, 12(6) MDPI 10.3390/vaccines12060662
Tan, Sean; Nelson, Adam J; Muthalaly, Rahul G; Ramkumar, Satish; Hamilton, Joshua; Nerlekar, Nitesh; Segelov, Eva; Nicholls, Stephen J (2024). Cardiovascular Risk in Cancer Patients Treated with Immune Checkpoint Inhibitors: Challenges and Future Directions. (In Press). European journal of preventive cardiology Oxford University Press 10.1093/eurjpc/zwae204
McPhee, Narelle J; Leach, Michael; Nightingale, Claire E; Harris, Samuel J; Segelov, Eva; Ristevski, Eli (2024). Differences in cancer clinical trial activity and trial characteristics at metropolitan and rural trial sites in Victoria, Australia. The Australian journal of rural health, 32(3), pp. 569-581. Wiley 10.1111/ajr.13102
Tan, Sean; Spear, Ella; Sane, Nikhita; Chan, Jasmine; Nelson, Adam J; Alamgeer, Muhammad; Nerlekar, Nitesh; Segelov, Eva; Nicholls, Stephen J (2024). Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study. Heart, lung & circulation, 33(5), pp. 721-729. Elsevier 10.1016/j.hlc.2023.10.008
Anaka, Matthew; Chan, David; Pattison, Sharon; Thawer, Alia; Franco, Bryan; Moody, Lesley; Jackson, Christopher; Segelov, Eva; Singh, Simron (2024). Patient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments. The oncologist, 29(3), pp. 227-234. AlphaMed Press 10.1093/oncolo/oyad312
Zhu, Hongcheng; Hao, Shengnan; Tseng, Ihsuan; Shen, Jingyi; Rivin Del Campo, Eleonor; Davies, Amy; Segelov, Eva; Liu, Qiufang; Chen, Yun; Song, Shaoli; Zhao, Kuaile (2023). Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review. Quantitative imaging in medicine and surgery, 13(9), pp. 6280-6295. AME Publishing Company 10.21037/qims-22-1306
Day, Daphne; Toh, Han Chong; Ali, Raghib; Foo, Estelle Mei Jye; Simes, John; Chia, John Whay Kuang; Segelov, Eva (2023). Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial. JCO global oncology, 9(e2300040), e2300040. American Society of Clinical Oncology 10.1200/GO.23.00040
Martina, Diah; Segelov, Eva (2023). Improving Equity Across Cancer Care Continuum in Asia Pacific. JCO global oncology, 9(e2300056), e2300056. American Society of Clinical Oncology 10.1200/GO.23.00056
Grech, Lisa; Kwok, Alastair; Nguyen, Mike; Winkel, Antony; Butler, Ernest; Allan, Michelle; Bain, Nathan; Segelov, Eva (2023). COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis. Vaccines, 11(2), p. 410. MDPI 10.3390/vaccines11020410
Choi, Tammie; Chan, Bryan; Grech, Lisa; Kwok, Alastair; Webber, Kate; Wong, Jennifer; Nguyen, Mike; Bain, Nathan; Day, Daphne; McCartney, Amelia; Hamer, Ruby; Segelov, Eva (2023). Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model. Vaccines, 11(2), p. 239. MDPI 10.3390/vaccines11020239
Day, D.; Starus, A.; Gebski, V.; Simes, J.; Hayes, T.; Padinharakam, S.; Strickland, A.H.; Briscoe, K.; Varma, S.; Barnet, M.; Jackson, C.; Horvath, L.G.; Price, T.J.; Tebbutt, N.; Karki, B.; Diakos, C.I.; Chia, J.; Toh, H.C.; Jones, F.S. and Segelov, Eva (October 2023). 586P Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial. Annals of oncology, 34(Suppl 2), S426-S427. Oxford University Press 10.1016/j.annonc.2023.09.1777
